The temporal relationship between lipoatrophy and lipohypertrophy in HIV-associated lipodystrophy

被引：0

作者：

Pewen, WF ^{[1
]}

Calhoun, BC ^{[1
]}

Riddler, SA ^{[1
]}

Kingsley, LA ^{[1
]}

机构：

[1] Univ Pittsburgh, Pittsburgh, PA 15260 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

100

引用

页码：L65 / L65

页数：1

共 50 条

[1] Lipoatrophy is the predominant presentation of HIV-associated lipodystrophy in southern India
Saghayam, S
Chaguturu, SK
Kumarasamy, N
Solomon, S
Mayer, KH
Wanke, C
[J]. CLINICAL INFECTIOUS DISEASES, 2004, 38 (11) : 1646 - 1647
[2] HIV-associated facial lipoatrophy
James, J
Carruthers, A
Carruthers, J
[J]. DERMATOLOGIC SURGERY, 2002, 28 (11) : 979 - 986
[3] Semaglutide in people with HIV-associated lipohypertrophy
Hwang, Y. Joseph
Brown, Todd
Capeau, Jacqueline
[J]. LANCET DIABETES & ENDOCRINOLOGY, 2024, 12 (08): : 504 - 505
[4] HIV-ASSOCIATED LIPODYSTROPHY AND EXERCISE
Mutimura, E.
Stewart, A.
Crowther, N. J.
[J]. SOUTH AFRICAN JOURNAL OF PHYSIOTHERAPY, 2006, 62 (02) : 2 - 4
[5] The HIV-associated lipodystrophy syndrome
Mauss, S
Schmutz, G
[J]. MEDIZINISCHE KLINIK, 2001, 96 (07): : 391 - 401
[6] HIV-associated lipodystrophy syndrome
Qaqish, RB
Fisher, E
Rublein, J
Wohl, DA
[J]. PHARMACOTHERAPY, 2000, 20 (01): : 13 - 22
[7] HIV-associated lipodystrophy syndrome
Milinkovic, Ana
[J]. COLLEGIUM ANTROPOLOGICUM, 2006, 30 : 59 - 62
[8] HIV-associated lipodystrophy syndrome
Mauss, S
[J]. AIDS, 2000, 14 : S197 - S207
[9] Cost consequences of HIV-associated lipoatrophy
Hornberger, J.
Rajagopalan, R.
Shewade, A.
Loutfy, M. R.
[J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2009, 21 (05): : 664 - 671
[10] Cost consequences of HIV-associated lipoatrophy
Hornberger, J.
Rajagopalan, R.
Shewade, A.
Loutfy, M.
[J]. ANTIVIRAL THERAPY, 2008, 13 (08) : A87 - A87